selank/dihexa Selank Peptide Neurologic & Psychiatric Peptides –

- Calves, young horses: 6 - 8 ml per head

Permanent discontinuation associated with an adverse reaction occurred in 43 of 444 (10%) patients receiving IBRANCE plus letrozole and in 13 of 222 (6%) patients receiving placebo plus letrozole

Cognitive Enhancement Moderate Research Research demonstrates Dihexa's remarkable cognitive enhancement properties in animal models, with studies showing improvements in spatial learning, working memory, and recognition memory tasks at extraordinarily low doses in the picomolar to nanomolar concentration range, making it potentially one of the most potent nootropic compounds ever discovered

10.1186/1742-2094-10-86 243 SelmajK

[PubMed 15784664] 25